Patient Corner

Latest drug updates

  • 28 Sep 2017 - Drug Updates

Patients on warfarin should not use over-the-counter Miconazole oral gel (Daktarin)

Patients on warfarin should take prescription-only miconazole oral gel and should seek immediate medical attention if they experience any signs of bleeding.

  • 28 Sep 2017 - Drug Updates

Loperamide (Imodium): Overdoses of loperamide associated with risk of serious cardiovascular events

Naloxone should be given as an antidote in case of overdoses of loperamide.

  • 23 Aug 2017 - Drug Updates

Local and systemic administration of corticosteroids: risk of central serous chorioretinopathy

Report any blurred vision or other visual disturbances during corticosteroid treatment.

  • 23 Aug 2017 - Drug Updates

Ibrutinib (Imbruvica▼): Reported cases of ventricular tachyarrhythmia and risk of hepatitis B reactivation and opportunistic infections

Discontinue ibrutinib in patients who develop symptoms suggestive of ventricular arrhythmia and be aware of the risk of hepatitis B virus reactivation and opportunistic infections.

  • 31 Jul 2017 - Drug Updates

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Initiate daclizumab in restricted groups of patients with limited treatment options and closely monitor liver function.

  • 28 Jul 2017 - Drug Updates

Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): Risk of graft rejection

Consider the benefit of treatment with nivolumab or pembrolizumab versus the risk of possible organ transplant rejection for each patient.

  • 28 Jul 2017 - Drug Updates

Bendamustine (Levact): Increased mortality when used in combination treatment outside the approved indications

Closely monitor patients for opportunistic infections as well as cardiac, neurological, and respiratory adverse events.

  • 27 Jun 2017 - Drug Updates

Restrictions to manage the risk for misuse of pseudoephedrine and ephedrine to be continued

Sale and supply of these products should be done under supervision of pharmacist or suitably trained pharmacy staff.

  • 27 Jun 2017 - Drug Updates

Denosumab (Prolia, Xgeva▼): Risk of osteonecrosis of jaw and external auditory canal

Advise patients to report any ear pain, discharge from ear, or an ear infection during denosumab treatment.

  • 27 Jun 2017 - Drug Updates

Brimonidine gel (Mirvaso): Risk of cardiovascular events if applied to damaged skin

Advise patients not to apply brimonidine gel to irritated or damaged skin.